Northern Arizona University will hold its fall commencement ceremonies next week. Honorary degrees to be awarded to Dr. Jeffrey Trent, president and scientific director of the Translational Genomics Research Institute in Phoenix along with Robert Breunig, the president and chief executive officer for the Museum of Northern Arizona.Continue reading
Category Archives: AZBio News
TGen Professor Dr. Frederic Zenhausern is named to Fellows of the National Academy of Inventors
Rapid DNA processor helps contribute to Arizona’s economic developmentContinue reading
Medtronic Initiates Global Clinical Trial for Miniature Transcatheter Pacemaker System
MINNEAPOLIS – December 9, 2013 – Continuing its leadership in advanced pacing technology and device miniaturization, Medtronic, Inc. (NYSE: MDT), today announced the first-in-human implant of the world’s smallest pacemaker: the Micra(TM) Transcatheter Pacing System (TPS). The device was implanted in a patient in Linz, Austria as part of the Medtronic global pivotal clinical trial. The Micra TPS is an investigational device worldwide.Continue reading
Venture Madness – a new kind of startup battle – apply today
Venture Madness, presented by Invest Southwest in partnership with Arizona Commerce Authority, is a competition where 64 startups from around the southwest will go head-to-head and compete for a portion of the $25,000 prize.
For the last 20 years, Invest Southwest, has been the premier capital conference in the region connecting investors with ventures and has had an “investment-centric focus” format, until this year. The event has gone through a serious transformation by responding to the needs of its audience and embracing the vibrancy of the startup community, starting with Venture Madness.
How Venture Madness works: Think of it as the “Battle of the Brackets” where startups duel it out bracket-style for the top slot. Thirty-two (of 64) bracket spots will be awarded to past participants from the Arizona Innovation Challenge (AIC); the remaining 32 spots will be filled through open enrollment. Startups from the southwest can apply today, December 6, 2013, through January 3, 2014.
Once the 64 ventures are established, there will be two online elimination rounds and 16 companies will advance to the live-demo rounds before a panel of judges on March 5-7, at Talking Stick Resort in Scottsdale.
Jonathan Ariano, chairman of Invest Southwest and Partner with Osborn Maledon, explains the new format and vibe, “Before, we used to have 12-14 companies go through a mentoring process to produce a ten minute presentation, with no Q&A, nor a contest-it was more of an investment-centric conference. When we went through the revamping process, we started thinking like a startup and asked ourselves ‘who is our customer?’ and spent months brainstorming on what that looked like. What we realized is that there are great programs and incubators that help entrepreneurs, but what was missing was the connective tissue…and that’s our job. We will be the connection to the investor community and showcasing what the Southwest has to offer-and the best way we can do that is Venture Madness.”
As part of the Venture Madness event, the organizers have weaved in more investor and startup connection opportunities including lunch-n-learns, cocktail parties and a Spring Training outing.
“We are really excited about this new format,” said Ariano. “There are a lot of great companies in the Southwest and the level of quality just keeps going up.”
Hey startups! Open enrollment starts now! Companies interested in participation must complete the online application, as well as create and submit a 90-second elevator pitch video. Applications and more information for Venture Madness, including detailed instructions, are available online at http://VentureMadness.com.
Venture Madness timeline:
- December 6, 2013: Startup application opens
- December 16, 2013: Event tickets available for purchase online
- January 3, 2014: Startup applications close
- February 3 – 14, 2014: First online elimination round with a 64 company bracket
- February 17 – 24, 2014: Second online elimination round with a 32 company bracket
- February 24, 2014: 16 companies to pitch live announced
- March 5, 2014: Venture Madness 2014 kicks off with an evening cocktail reception at Talking Stick Resort
- March 6, 2014: Third elimination round, 16 companies to pitch live
- March 7, 2014: Elimination rounds four – six; Venture Madness Champion announced
Source: http://aztechbeat.com/2013/12/venture-madness-new-kind-of-startup-battle-applications-open-today/
FedEx® Deep Frozen Shipping Solution now part of BIO Business Solutions
BIO Business Solutions® has teamed up with FedEx to now include specialized deep frozen shipping solutions to member companies. The FedEx® Deep Frozen Shipping Solution provides innovative liquid nitrogen dry vapor technology via a cryogenic dewar along with end-to-end shipment monitoring and visibility. Specifically suited for preserving the integrity of biogenics, this solution provides up to 10 days of holding time at temperature ranges down to -150˚C. The solution offers member companies several advantages:
- Keeps tissue samples and substances deep-frozen at -150°C
- Provides up to 10 days without need for dry ice or power
- Meets International Air Transport Association (IATA) requirements for both infectious substances (UN3373) and non-infectious clinical samples
- Eliminates inventory of insulated boxes and dry ice
- Provides advanced tracking and proactive monitoring via FedEx Priority AlertTM.
- FedEx provides end-to-end solutions to help your temperature sensitive products maintain optimum temperature while in transit across the nation or across the ocean.
Member Benefits
Discounted Flat Fee of $435 for Domestic or $750 for international shipment
Enrollment
To enroll in the FedEx® Deep Frozen Shipping Solution, click below:
More Information
For more information on FedEx® Deep Frozen Shipping Solution, call 1-888-370-3971
FedEx® Deep Frozen Shipping Solution Case Study
Read the case study below to learn how Cenetron Diagnostics was successful using the FedEx® Deep Frozen Shipping Solution to cost effectively transport and track temperature sensitive clinical trial shipments and to learn how businesses like yours are taking advantage of powerful integration solutions with FedEx. As a reminder, FedEx Web Services allows you to integrate FedEx® shipping, tracking, rating, address validation, reporting tools, and more, directly into your website.
Read more here: Cenetron_Case_Study.pdf
Eligible Affiliates
All AZBio and BIO members are eligible to utilize the BIO Business Solutions® program with FedEx.
NASA, CASIS Make Space Station Accessible for Stem Cell Research
Opportunity Alert: ECONOMIC RESEARCH ANALYST at ACA
The Arizona Commerce Authority is seeking an economic research analyst to join its top-notch research team in Phoenix. The ACA’s mission is to grow and strengthen Arizona’s economy and facilitate the creation of quality jobs in the state by supporting and attracting businesses in targeted, high-value base sectors. The research team compiles and analyzes economic data to assist in business attraction, business development and business retention.Continue reading
TGen, Barrow Neurological Institute and Phoenix Children’s Hospital receive $4 million grant to study genetic basis of brain injuries
NIH grant to identify biomarker for secondary injuries associated with ruptured brain aneurysms and subarachnoid hemorrhageContinue reading
Ventana Medical Receives FDA 510(k) Clearance for Companion Algorithm ER (SP1)
Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Companion Algorithm ER (SP1)1 image analysis algorithm used with the VENTANA iScan Coreo scanner running Virtuoso2 software. With this clearance, Ventana is now the only company in the industry offering a comprehensive portfolio of FDA-cleared image analysis algorithms and digital read applications for the five key immunohistochemistry (IHC) breast markers. Continue reading
Cancer Prevention Pharmaceuticals launches double-blind, randomized, Phase III trial
Phase III Familial Adenomatous Polyposis (FAP) Trial Now Open for EnrollmentContinue reading